降低风险的卵巢切除术后患者的更年期症状管理
Andrew M Kaunitz1, Chanda Reese, JoAnn V Pinkerton
1Department of Obstetrics and Gynecology, University of Florida College of Medicine - Jacksonville, Jacksonville, Florida; and the Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, Virginia.
Obstetrics and gynecology
|July 17, 2025
概括
接受风险降低手术的BRCA1/2突变患者可以安全地使用更年期激素治疗. 观察数据表明,它不会增加乳腺癌的风险,改善生活质量和减少早期更年期的风险.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 妇科 妇科 妇科 妇科
背景情况:
- 由于BRCA1/2突变增加了癌症的风险,因此需要进行双边salpingo-oophorectomy (BSO) 等降低风险的手术.
- 由于患有乳腺癌的担忧,患者面临更年期激素治疗 (MHT) 安全性的困境.
- 在45岁之前由BSO引起的过早更年期对健康构成重大风险.
研究的目的:
- 在降低风险的BSO之后,评估MHT在BRCA1/2突变载体中的安全性和影响.
- 为改善生活质量和减轻与更年期相关的健康风险提供有关MHT的临床决策的信息.
主要方法:
- 对BRCA1/2突变患者的观察数据分析.
- 专注于那些在45岁之前接受了降低风险的BSO并保持完整的乳房的人.
- 与全身MHT使用相关的乳腺癌风险评估.
主要成果:
- 系统性MHT在这个特定的患者队列中没有提高乳腺癌风险.
- MHT与改善生活质量有关.
- MHT可能会降低与过早更年期相关的健康风险.
结论:
- 更年期荷尔蒙疗法是BRCA1/2突变携带者在BSO后与乳房完好无损的可行选择.
- 考虑MHT可以提高幸福感并减少长期的健康并发症.
- 新出现的数据表明,仅用雌激素治疗可能会降低乳腺癌的风险,因此在降低风险的过程中,与子宫切除术一起进行进一步的研究是有必要的.
更多相关视频
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
12.3K
08:46Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
6.1K
相关概念视频
01:28Menopause
252
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
252
01:24Disorders of the Female Reproductive System
496
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
496
01:30Hormonal Control of the Ovarian Cycle
3.1K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
3.1K
01:22Hormonal Regulation of the Menstrual Cycle
708
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
708
02:07Oogenesis
64.4K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
64.4K
01:19Mitral Valve Prolapse III: Nursing Management
39
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
39